Fingerpaint Branding's Recent Pharmaceutical and Non-Proprietary Approvals
Fingerpaint Branding is proud to support pharmaceutical and life sciences companies around the globe with naming, visual identity, brand strategy, market research, and regulatory guidance. Here are a few of our most recent brand name and non-proprietary name approvals.

adrulipase alfa
alnuctamab
anumigilimab
anzurstobart
atamparib
avutometinib
bezetabart debotansine
bomedemstat
bomtabegagene bavoparvovec
brexucabtagene autoleucel
camizestrant
casirivimab/imdevimab
cavrotolimod
cliramitug
dimebutic acid
dordaviprone
dovramilast
duvakitug
eclitasertib
efzimfotase alfa
eganelisib
eladocagene exuparvovec
emvododstat
eragidomide
erepdekinra
fasedienol
feniralstat
fosgonimeton
frexalimab
gemlapodect
golcadomide
gorivitug
idecabtagene vicleucel
imaradenant
inaxaplin
ispectamab tazide
itruvone
luveltamab tazevibulin
luvixasertib
modakafusp alfa
nadravaleucel
nexiguran
ocifisertib
onvansertib
oplunofusp
orpibestrant
palupiprant
pelecopan
pezadeftide
plixorafenib
pomlucabtagene autoleucel
rencofilstat
revumenib
rifaquizinone
rifasutenizol
rilunermin alfa
rovaleucel
sepiapterin
taniraleucel
tiomolibdic acid/tiomolibdate choline
trotabresib
tulisokibart
ultevursen
ulviprubart
unesbulin
upifitamab rilsodotin
utreloxastat
vanzacaftor
varokibart
veligrotug
vepdegestrant
vevoctadekin
vipivotide tetraxetan
voluloride
zelenectide pevedotin
zeltociclib
ziclumeran
zimislecel
To learn more about our creative services or speak with a branding expert, please contact us.
Author: Brittany Scott Last Updated: February 28, 2025